Aclaris Therapeutics (ACRS) Cash from Financing Activities (2014 - 2026)
Aclaris Therapeutics (ACRS) recorded Cash from Financing Activities of $91,000 in Q2 2026, compared with -$9,000 a year earlier and down 99.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Cash from Financing Activities (2014 - 2026) Analysis & Trends
On a TTM basis, Aclaris Therapeutics' Cash from Financing Activities came in at $52.29 million as of Jun 30, 2026, down 29.6% year-over-year; for FY2025, it was -$5.86 million.
- Across earlier years, Cash from Financing Activities came in at $74.54 million in FY2024 (+179.1%), $26.71 million in FY2023 (-63.3%), $72.87 million in FY2022 (-67.6%) and $225.05 million in FY2021.
- Quarterly Cash from Financing Activities has ranged from -$11.57 million in Q3 2021 to $74.58 million in Q4 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at $57.78 million (Q1 2026), -$2.53 million (Q4 2025) and -$3.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91,000.00 |
| Mar 31, 2026 | 57.78 Mn |
| Dec 31, 2025 | -2.53 Mn |
| Sep 30, 2025 | -3.04 Mn |
| Jun 30, 2025 | -9,000.00 |
| Mar 31, 2025 | -275,000.00 |
| Dec 31, 2024 | 74.58 Mn |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -55,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | -87,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | 72.81 Mn |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -11.57 Mn |
| Jun 30, 2021 | 135.87 Mn |
| Mar 31, 2021 | 100.75 Mn |
API Access
Aclaris Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();